Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn.
Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn. Subsequent developments will address cardiology and 4D imaging. Previous and new investors include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, and Siemens Venture Capital.
The company is being directed by new president and CEO Donald J. Southard, who joined the firm last month after serving as president of Datascope's $160 million patient monitoring business.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.